CD19 and acute lymphoblastic leukemia: Finally, although the cytometrically assessed proportions of calpastatin-positive cells did not differ between the BM CD19+ ALL blasts and nonmalignant B cells, the actual levels of calpastatin expressed as corrected MFI were significantly lower in the blasts (Fig 3).